nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA14—Zoledronate—Paget's disease of bone	0.303	0.438	CbGbCtD
Imatinib—CA12—Zoledronate—Paget's disease of bone	0.215	0.311	CbGbCtD
Imatinib—CA2—Zoledronate—Paget's disease of bone	0.174	0.251	CbGbCtD
Imatinib—CSF1R—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.00213	0.0519	CbGpPWpGaD
Imatinib—PDGFRA—Osteoblast Signaling—TNFRSF11B—Paget's disease of bone	0.00206	0.0501	CbGpPWpGaD
Imatinib—PDGFRB—Osteoblast Signaling—TNFRSF11B—Paget's disease of bone	0.00185	0.0451	CbGpPWpGaD
Imatinib—PDGFRA—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.00185	0.0449	CbGpPWpGaD
Imatinib—CSF1R—Differentiation Pathway—CSF1—Paget's disease of bone	0.00184	0.0448	CbGpPWpGaD
Imatinib—CSF1R—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.00173	0.042	CbGpPWpGaD
Imatinib—PDGFRB—Osteoblast Signaling—BGLAP—Paget's disease of bone	0.00166	0.0405	CbGpPWpGaD
Imatinib—CSF1R—Integrins in angiogenesis—CSF1—Paget's disease of bone	0.00148	0.0361	CbGpPWpGaD
Imatinib—LCK—PECAM1 interactions—INPP5D—Paget's disease of bone	0.00145	0.0352	CbGpPWpGaD
Imatinib—KIT—Differentiation Pathway—CSF1—Paget's disease of bone	0.000921	0.0224	CbGpPWpGaD
Imatinib—PDGFRB—Signaling events mediated by TCPTP—CSF1—Paget's disease of bone	0.000909	0.0221	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—TNFRSF11A—Paget's disease of bone	0.000809	0.0197	CbGpPWpGaD
Imatinib—PDGFRB—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.000737	0.0179	CbGpPWpGaD
Imatinib—NTRK1—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.000705	0.0171	CbGpPWpGaD
Imatinib—NTRK1—p73 transcription factor network—PML—Paget's disease of bone	0.000663	0.0161	CbGpPWpGaD
Imatinib—NTRK1—p75(NTR)-mediated signaling—SQSTM1—Paget's disease of bone	0.000639	0.0155	CbGpPWpGaD
Imatinib—KIT—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.000592	0.0144	CbGpPWpGaD
Imatinib—LCK—Signaling events mediated by PTP1B—CSF1—Paget's disease of bone	0.000591	0.0144	CbGpPWpGaD
Imatinib—ABCA3—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000582	0.0142	CbGpPWpGaD
Imatinib—ABL1—Validated transcriptional targets of TAp63 isoforms—PML—Paget's disease of bone	0.000547	0.0133	CbGpPWpGaD
Imatinib—LCK—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.000542	0.0132	CbGpPWpGaD
Imatinib—LCK—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.000503	0.0122	CbGpPWpGaD
Imatinib—LCK—Interleukin-2 signaling—INPP5D—Paget's disease of bone	0.000486	0.0118	CbGpPWpGaD
Imatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.00048	0.0117	CbGpPWpGaD
Imatinib—ABL1—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.000469	0.0114	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response—PML—Paget's disease of bone	0.000455	0.0111	CbGpPWpGaD
Imatinib—NTRK1—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000445	0.0108	CbGpPWpGaD
Imatinib—ABL1—miRNA Regulation of DNA Damage Response—PML—Paget's disease of bone	0.00044	0.0107	CbGpPWpGaD
Imatinib—ABL1—Neurotrophic factor-mediated Trk receptor signaling—SQSTM1—Paget's disease of bone	0.000429	0.0104	CbGpPWpGaD
Imatinib—SLC47A1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000424	0.0103	CbGpPWpGaD
Imatinib—LCK—TCR signaling—INPP5D—Paget's disease of bone	0.000405	0.00985	CbGpPWpGaD
Imatinib—ABL1—p73 transcription factor network—PML—Paget's disease of bone	0.000404	0.00981	CbGpPWpGaD
Imatinib—LCK—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.00037	0.009	CbGpPWpGaD
Imatinib—Malaise—Alendronate—Paget's disease of bone	0.000369	0.00138	CcSEcCtD
Imatinib—Vertigo—Alendronate—Paget's disease of bone	0.000367	0.00137	CcSEcCtD
Imatinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.000364	0.00136	CcSEcCtD
Imatinib—Infestation—Zoledronate—Paget's disease of bone	0.000364	0.00136	CcSEcCtD
Imatinib—Depression—Zoledronate—Paget's disease of bone	0.000363	0.00136	CcSEcCtD
Imatinib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00036	0.00134	CcSEcCtD
Imatinib—CA9—Cellular responses to stress—VCP—Paget's disease of bone	0.000359	0.00874	CbGpPWpGaD
Imatinib—Rhinitis—Pamidronate—Paget's disease of bone	0.000359	0.00134	CcSEcCtD
Imatinib—Renal failure—Zoledronate—Paget's disease of bone	0.000358	0.00134	CcSEcCtD
Imatinib—Haemorrhage—Pamidronate—Paget's disease of bone	0.000358	0.00134	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.000357	0.00133	CcSEcCtD
Imatinib—Stomatitis—Zoledronate—Paget's disease of bone	0.000355	0.00133	CcSEcCtD
Imatinib—NTRK1—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000355	0.00862	CbGpPWpGaD
Imatinib—Urinary tract infection—Zoledronate—Paget's disease of bone	0.000354	0.00132	CcSEcCtD
Imatinib—Conjunctivitis—Zoledronate—Paget's disease of bone	0.000354	0.00132	CcSEcCtD
Imatinib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.000354	0.00132	CcSEcCtD
Imatinib—Eye disorder—Risedronate—Paget's disease of bone	0.000352	0.00131	CcSEcCtD
Imatinib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.000352	0.00131	CcSEcCtD
Imatinib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.000351	0.00131	CcSEcCtD
Imatinib—Tinnitus—Risedronate—Paget's disease of bone	0.000351	0.00131	CcSEcCtD
Imatinib—Urethral disorder—Pamidronate—Paget's disease of bone	0.000351	0.00131	CcSEcCtD
Imatinib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00035	0.00131	CcSEcCtD
Imatinib—Myalgia—Alendronate—Paget's disease of bone	0.000348	0.0013	CcSEcCtD
Imatinib—Chest pain—Alendronate—Paget's disease of bone	0.000348	0.0013	CcSEcCtD
Imatinib—Haematuria—Zoledronate—Paget's disease of bone	0.000347	0.0013	CcSEcCtD
Imatinib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.000345	0.00129	CcSEcCtD
Imatinib—Discomfort—Alendronate—Paget's disease of bone	0.000344	0.00128	CcSEcCtD
Imatinib—Angiopathy—Risedronate—Paget's disease of bone	0.000342	0.00128	CcSEcCtD
Imatinib—Immune system disorder—Risedronate—Paget's disease of bone	0.00034	0.00127	CcSEcCtD
Imatinib—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00034	0.00127	CcSEcCtD
Imatinib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.000339	0.00127	CcSEcCtD
Imatinib—Arrhythmia—Risedronate—Paget's disease of bone	0.000336	0.00126	CcSEcCtD
Imatinib—Constipation—Etidronic acid—Paget's disease of bone	0.000335	0.00125	CcSEcCtD
Imatinib—Eye disorder—Pamidronate—Paget's disease of bone	0.000335	0.00125	CcSEcCtD
Imatinib—Flushing—Pamidronate—Paget's disease of bone	0.000332	0.00124	CcSEcCtD
Imatinib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.000332	0.00124	CcSEcCtD
Imatinib—Infection—Alendronate—Paget's disease of bone	0.000331	0.00124	CcSEcCtD
Imatinib—Mental disorder—Risedronate—Paget's disease of bone	0.00033	0.00123	CcSEcCtD
Imatinib—Malnutrition—Risedronate—Paget's disease of bone	0.000328	0.00122	CcSEcCtD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000327	0.00795	CbGpPWpGaD
Imatinib—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.000325	0.00122	CcSEcCtD
Imatinib—Angiopathy—Pamidronate—Paget's disease of bone	0.000325	0.00121	CcSEcCtD
Imatinib—Immune system disorder—Pamidronate—Paget's disease of bone	0.000323	0.00121	CcSEcCtD
Imatinib—Flatulence—Risedronate—Paget's disease of bone	0.000323	0.00121	CcSEcCtD
Imatinib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000323	0.00121	CcSEcCtD
Imatinib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000323	0.00121	CcSEcCtD
Imatinib—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000323	0.0012	CcSEcCtD
Imatinib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.000322	0.0012	CcSEcCtD
Imatinib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.000321	0.0012	CcSEcCtD
Imatinib—Chills—Pamidronate—Paget's disease of bone	0.000321	0.0012	CcSEcCtD
Imatinib—Urethral disorder—Zoledronate—Paget's disease of bone	0.000321	0.0012	CcSEcCtD
Imatinib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00032	0.0012	CcSEcCtD
Imatinib—Back pain—Risedronate—Paget's disease of bone	0.000317	0.00118	CcSEcCtD
Imatinib—Alopecia—Pamidronate—Paget's disease of bone	0.000316	0.00118	CcSEcCtD
Imatinib—Muscle spasms—Risedronate—Paget's disease of bone	0.000315	0.00118	CcSEcCtD
Imatinib—NTRK1—Circadian rythm related genes—PML—Paget's disease of bone	0.000314	0.00764	CbGpPWpGaD
Imatinib—Malnutrition—Pamidronate—Paget's disease of bone	0.000312	0.00116	CcSEcCtD
Imatinib—Erythema—Pamidronate—Paget's disease of bone	0.000312	0.00116	CcSEcCtD
Imatinib—Urticaria—Etidronic acid—Paget's disease of bone	0.000311	0.00116	CcSEcCtD
Imatinib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000309	0.00116	CcSEcCtD
Imatinib—Eye disorder—Zoledronate—Paget's disease of bone	0.000306	0.00114	CcSEcCtD
Imatinib—LCK—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.000305	0.00742	CbGpPWpGaD
Imatinib—Dysgeusia—Pamidronate—Paget's disease of bone	0.000305	0.00114	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000304	0.00113	CcSEcCtD
Imatinib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000304	0.00113	CcSEcCtD
Imatinib—Flushing—Zoledronate—Paget's disease of bone	0.000304	0.00113	CcSEcCtD
Imatinib—Anaemia—Risedronate—Paget's disease of bone	0.000303	0.00113	CcSEcCtD
Imatinib—Back pain—Pamidronate—Paget's disease of bone	0.000301	0.00113	CcSEcCtD
Imatinib—Muscle spasms—Pamidronate—Paget's disease of bone	0.0003	0.00112	CcSEcCtD
Imatinib—Angioedema—Risedronate—Paget's disease of bone	0.0003	0.00112	CcSEcCtD
Imatinib—Angiopathy—Zoledronate—Paget's disease of bone	0.000297	0.00111	CcSEcCtD
Imatinib—Immune system disorder—Zoledronate—Paget's disease of bone	0.000295	0.0011	CcSEcCtD
Imatinib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.000295	0.0011	CcSEcCtD
Imatinib—Vertigo—Risedronate—Paget's disease of bone	0.000295	0.0011	CcSEcCtD
Imatinib—Syncope—Risedronate—Paget's disease of bone	0.000294	0.0011	CcSEcCtD
Imatinib—Dyspepsia—Alendronate—Paget's disease of bone	0.000294	0.0011	CcSEcCtD
Imatinib—Chills—Zoledronate—Paget's disease of bone	0.000293	0.0011	CcSEcCtD
Imatinib—Arrhythmia—Zoledronate—Paget's disease of bone	0.000292	0.00109	CcSEcCtD
Imatinib—ALB—Folate Metabolism—CSF1—Paget's disease of bone	0.000292	0.0071	CbGpPWpGaD
Imatinib—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.000289	0.00108	CcSEcCtD
Imatinib—Alopecia—Zoledronate—Paget's disease of bone	0.000289	0.00108	CcSEcCtD
Imatinib—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.000288	0.00108	CcSEcCtD
Imatinib—Loss of consciousness—Risedronate—Paget's disease of bone	0.000288	0.00108	CcSEcCtD
Imatinib—Anaemia—Pamidronate—Paget's disease of bone	0.000288	0.00108	CcSEcCtD
Imatinib—Mental disorder—Zoledronate—Paget's disease of bone	0.000287	0.00107	CcSEcCtD
Imatinib—Cough—Risedronate—Paget's disease of bone	0.000286	0.00107	CcSEcCtD
Imatinib—Pain—Alendronate—Paget's disease of bone	0.000285	0.00107	CcSEcCtD
Imatinib—Constipation—Alendronate—Paget's disease of bone	0.000285	0.00107	CcSEcCtD
Imatinib—Angioedema—Pamidronate—Paget's disease of bone	0.000285	0.00106	CcSEcCtD
Imatinib—Erythema—Zoledronate—Paget's disease of bone	0.000285	0.00106	CcSEcCtD
Imatinib—Malnutrition—Zoledronate—Paget's disease of bone	0.000285	0.00106	CcSEcCtD
Imatinib—Hypertension—Risedronate—Paget's disease of bone	0.000283	0.00106	CcSEcCtD
Imatinib—Malaise—Pamidronate—Paget's disease of bone	0.000281	0.00105	CcSEcCtD
Imatinib—Syncope—Pamidronate—Paget's disease of bone	0.00028	0.00104	CcSEcCtD
Imatinib—Chest pain—Risedronate—Paget's disease of bone	0.000279	0.00104	CcSEcCtD
Imatinib—Myalgia—Risedronate—Paget's disease of bone	0.000279	0.00104	CcSEcCtD
Imatinib—Arthralgia—Risedronate—Paget's disease of bone	0.000279	0.00104	CcSEcCtD
Imatinib—Leukopenia—Pamidronate—Paget's disease of bone	0.000279	0.00104	CcSEcCtD
Imatinib—Dysgeusia—Zoledronate—Paget's disease of bone	0.000279	0.00104	CcSEcCtD
Imatinib—Anxiety—Risedronate—Paget's disease of bone	0.000278	0.00104	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.000277	0.00104	CcSEcCtD
Imatinib—Pruritus—Etidronic acid—Paget's disease of bone	0.000277	0.00103	CcSEcCtD
Imatinib—Back pain—Zoledronate—Paget's disease of bone	0.000275	0.00103	CcSEcCtD
Imatinib—Feeling abnormal—Alendronate—Paget's disease of bone	0.000275	0.00103	CcSEcCtD
Imatinib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.000274	0.00102	CcSEcCtD
Imatinib—Muscle spasms—Zoledronate—Paget's disease of bone	0.000274	0.00102	CcSEcCtD
Imatinib—Dry mouth—Risedronate—Paget's disease of bone	0.000273	0.00102	CcSEcCtD
Imatinib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000273	0.00102	CcSEcCtD
Imatinib—LCK—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000272	0.00662	CbGpPWpGaD
Imatinib—Cough—Pamidronate—Paget's disease of bone	0.000272	0.00102	CcSEcCtD
Imatinib—Convulsion—Pamidronate—Paget's disease of bone	0.00027	0.00101	CcSEcCtD
Imatinib—Hypertension—Pamidronate—Paget's disease of bone	0.000269	0.00101	CcSEcCtD
Imatinib—Vision blurred—Zoledronate—Paget's disease of bone	0.000268	0.001	CcSEcCtD
Imatinib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000268	0.001	CcSEcCtD
Imatinib—LCK—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000268	0.00651	CbGpPWpGaD
Imatinib—Tremor—Zoledronate—Paget's disease of bone	0.000267	0.000996	CcSEcCtD
Imatinib—Infection—Risedronate—Paget's disease of bone	0.000266	0.000993	CcSEcCtD
Imatinib—Arthralgia—Pamidronate—Paget's disease of bone	0.000265	0.000991	CcSEcCtD
Imatinib—Myalgia—Pamidronate—Paget's disease of bone	0.000265	0.000991	CcSEcCtD
Imatinib—Urticaria—Alendronate—Paget's disease of bone	0.000265	0.00099	CcSEcCtD
Imatinib—Anxiety—Pamidronate—Paget's disease of bone	0.000264	0.000988	CcSEcCtD
Imatinib—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.000264	0.000987	CcSEcCtD
Imatinib—Abdominal pain—Alendronate—Paget's disease of bone	0.000264	0.000985	CcSEcCtD
Imatinib—Body temperature increased—Alendronate—Paget's disease of bone	0.000264	0.000985	CcSEcCtD
Imatinib—Shock—Risedronate—Paget's disease of bone	0.000263	0.000983	CcSEcCtD
Imatinib—Anaemia—Zoledronate—Paget's disease of bone	0.000263	0.000983	CcSEcCtD
Imatinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.000262	0.00098	CcSEcCtD
Imatinib—Discomfort—Pamidronate—Paget's disease of bone	0.000262	0.000979	CcSEcCtD
Imatinib—Angioedema—Zoledronate—Paget's disease of bone	0.00026	0.000972	CcSEcCtD
Imatinib—Skin disorder—Risedronate—Paget's disease of bone	0.00026	0.000971	CcSEcCtD
Imatinib—LCK—Host Interactions of HIV factors—NUP205—Paget's disease of bone	0.000259	0.00629	CbGpPWpGaD
Imatinib—Malaise—Zoledronate—Paget's disease of bone	0.000257	0.000959	CcSEcCtD
Imatinib—Confusional state—Pamidronate—Paget's disease of bone	0.000256	0.000958	CcSEcCtD
Imatinib—Vertigo—Zoledronate—Paget's disease of bone	0.000256	0.000955	CcSEcCtD
Imatinib—Syncope—Zoledronate—Paget's disease of bone	0.000255	0.000954	CcSEcCtD
Imatinib—Leukopenia—Zoledronate—Paget's disease of bone	0.000255	0.000952	CcSEcCtD
Imatinib—Oedema—Pamidronate—Paget's disease of bone	0.000254	0.00095	CcSEcCtD
Imatinib—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.000254	0.00095	CcSEcCtD
Imatinib—Infection—Pamidronate—Paget's disease of bone	0.000253	0.000944	CcSEcCtD
Imatinib—Palpitations—Zoledronate—Paget's disease of bone	0.000252	0.00094	CcSEcCtD
Imatinib—Shock—Pamidronate—Paget's disease of bone	0.00025	0.000935	CcSEcCtD
Imatinib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00025	0.000935	CcSEcCtD
Imatinib—LCK—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00025	0.00607	CbGpPWpGaD
Imatinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.000249	0.000932	CcSEcCtD
Imatinib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000249	0.00093	CcSEcCtD
Imatinib—Vomiting—Etidronic acid—Paget's disease of bone	0.000249	0.00093	CcSEcCtD
Imatinib—Cough—Zoledronate—Paget's disease of bone	0.000248	0.000928	CcSEcCtD
Imatinib—Tachycardia—Pamidronate—Paget's disease of bone	0.000248	0.000927	CcSEcCtD
Imatinib—Rash—Etidronic acid—Paget's disease of bone	0.000247	0.000922	CcSEcCtD
Imatinib—Convulsion—Zoledronate—Paget's disease of bone	0.000247	0.000921	CcSEcCtD
Imatinib—Dermatitis—Etidronic acid—Paget's disease of bone	0.000247	0.000921	CcSEcCtD
Imatinib—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.000246	0.000919	CcSEcCtD
Imatinib—Hypertension—Zoledronate—Paget's disease of bone	0.000246	0.000918	CcSEcCtD
Imatinib—Hypersensitivity—Alendronate—Paget's disease of bone	0.000246	0.000918	CcSEcCtD
Imatinib—Headache—Etidronic acid—Paget's disease of bone	0.000245	0.000916	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000244	0.000911	CcSEcCtD
Imatinib—Anorexia—Pamidronate—Paget's disease of bone	0.000242	0.000906	CcSEcCtD
Imatinib—Chest pain—Zoledronate—Paget's disease of bone	0.000242	0.000905	CcSEcCtD
Imatinib—Arthralgia—Zoledronate—Paget's disease of bone	0.000242	0.000905	CcSEcCtD
Imatinib—Myalgia—Zoledronate—Paget's disease of bone	0.000242	0.000905	CcSEcCtD
Imatinib—Insomnia—Risedronate—Paget's disease of bone	0.000242	0.000904	CcSEcCtD
Imatinib—Anxiety—Zoledronate—Paget's disease of bone	0.000242	0.000902	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000241	0.000899	CcSEcCtD
Imatinib—ABL1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.00024	0.00584	CbGpPWpGaD
Imatinib—Paraesthesia—Risedronate—Paget's disease of bone	0.00024	0.000898	CcSEcCtD
Imatinib—Discomfort—Zoledronate—Paget's disease of bone	0.000239	0.000895	CcSEcCtD
Imatinib—Asthenia—Alendronate—Paget's disease of bone	0.000239	0.000894	CcSEcCtD
Imatinib—Dyspnoea—Risedronate—Paget's disease of bone	0.000239	0.000891	CcSEcCtD
Imatinib—Hypotension—Pamidronate—Paget's disease of bone	0.000238	0.000888	CcSEcCtD
Imatinib—Dry mouth—Zoledronate—Paget's disease of bone	0.000237	0.000885	CcSEcCtD
Imatinib—Pruritus—Alendronate—Paget's disease of bone	0.000236	0.000881	CcSEcCtD
Imatinib—Dyspepsia—Risedronate—Paget's disease of bone	0.000236	0.00088	CcSEcCtD
Imatinib—Confusional state—Zoledronate—Paget's disease of bone	0.000234	0.000875	CcSEcCtD
Imatinib—Nausea—Etidronic acid—Paget's disease of bone	0.000232	0.000868	CcSEcCtD
Imatinib—Oedema—Zoledronate—Paget's disease of bone	0.000232	0.000868	CcSEcCtD
Imatinib—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.000232	0.000868	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000232	0.000866	CcSEcCtD
Imatinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000231	0.000863	CcSEcCtD
Imatinib—Infection—Zoledronate—Paget's disease of bone	0.000231	0.000862	CcSEcCtD
Imatinib—Fatigue—Risedronate—Paget's disease of bone	0.000231	0.000862	CcSEcCtD
Imatinib—Insomnia—Pamidronate—Paget's disease of bone	0.00023	0.000859	CcSEcCtD
Imatinib—Constipation—Risedronate—Paget's disease of bone	0.000229	0.000855	CcSEcCtD
Imatinib—Pain—Risedronate—Paget's disease of bone	0.000229	0.000855	CcSEcCtD
Imatinib—Shock—Zoledronate—Paget's disease of bone	0.000229	0.000854	CcSEcCtD
Imatinib—Paraesthesia—Pamidronate—Paget's disease of bone	0.000228	0.000853	CcSEcCtD
Imatinib—Diarrhoea—Alendronate—Paget's disease of bone	0.000228	0.000852	CcSEcCtD
Imatinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000228	0.000851	CcSEcCtD
Imatinib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000228	0.00085	CcSEcCtD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000227	0.00552	CbGpPWpGaD
Imatinib—Dyspnoea—Pamidronate—Paget's disease of bone	0.000227	0.000847	CcSEcCtD
Imatinib—Tachycardia—Zoledronate—Paget's disease of bone	0.000227	0.000847	CcSEcCtD
Imatinib—Somnolence—Pamidronate—Paget's disease of bone	0.000226	0.000845	CcSEcCtD
Imatinib—Skin disorder—Zoledronate—Paget's disease of bone	0.000226	0.000843	CcSEcCtD
Imatinib—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000225	0.000839	CcSEcCtD
Imatinib—Dyspepsia—Pamidronate—Paget's disease of bone	0.000224	0.000836	CcSEcCtD
Imatinib—LCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000224	0.00544	CbGpPWpGaD
Imatinib—Anorexia—Zoledronate—Paget's disease of bone	0.000221	0.000827	CcSEcCtD
Imatinib—Decreased appetite—Pamidronate—Paget's disease of bone	0.000221	0.000826	CcSEcCtD
Imatinib—Dizziness—Alendronate—Paget's disease of bone	0.000221	0.000824	CcSEcCtD
Imatinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00022	0.00082	CcSEcCtD
Imatinib—Fatigue—Pamidronate—Paget's disease of bone	0.000219	0.000819	CcSEcCtD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000219	0.00533	CbGpPWpGaD
Imatinib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.000219	0.000817	CcSEcCtD
Imatinib—Pain—Pamidronate—Paget's disease of bone	0.000218	0.000813	CcSEcCtD
Imatinib—Constipation—Pamidronate—Paget's disease of bone	0.000218	0.000813	CcSEcCtD
Imatinib—Hypotension—Zoledronate—Paget's disease of bone	0.000217	0.000811	CcSEcCtD
Imatinib—SLC47A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000215	0.00524	CbGpPWpGaD
Imatinib—Urticaria—Risedronate—Paget's disease of bone	0.000213	0.000794	CcSEcCtD
Imatinib—Vomiting—Alendronate—Paget's disease of bone	0.000212	0.000792	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000212	0.000791	CcSEcCtD
Imatinib—Abdominal pain—Risedronate—Paget's disease of bone	0.000212	0.00079	CcSEcCtD
Imatinib—Body temperature increased—Risedronate—Paget's disease of bone	0.000212	0.00079	CcSEcCtD
Imatinib—Rash—Alendronate—Paget's disease of bone	0.00021	0.000785	CcSEcCtD
Imatinib—Insomnia—Zoledronate—Paget's disease of bone	0.00021	0.000785	CcSEcCtD
Imatinib—Dermatitis—Alendronate—Paget's disease of bone	0.00021	0.000785	CcSEcCtD
Imatinib—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00021	0.000783	CcSEcCtD
Imatinib—Headache—Alendronate—Paget's disease of bone	0.000209	0.00078	CcSEcCtD
Imatinib—Paraesthesia—Zoledronate—Paget's disease of bone	0.000209	0.000779	CcSEcCtD
Imatinib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000208	0.000777	CcSEcCtD
Imatinib—Dyspnoea—Zoledronate—Paget's disease of bone	0.000207	0.000774	CcSEcCtD
Imatinib—Somnolence—Zoledronate—Paget's disease of bone	0.000207	0.000772	CcSEcCtD
Imatinib—NTRK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000205	0.00498	CbGpPWpGaD
Imatinib—Dyspepsia—Zoledronate—Paget's disease of bone	0.000205	0.000764	CcSEcCtD
Imatinib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000202	0.000755	CcSEcCtD
Imatinib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000201	0.000751	CcSEcCtD
Imatinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000201	0.000751	CcSEcCtD
Imatinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000201	0.000749	CcSEcCtD
Imatinib—Fatigue—Zoledronate—Paget's disease of bone	0.0002	0.000748	CcSEcCtD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000199	0.00484	CbGpPWpGaD
Imatinib—Constipation—Zoledronate—Paget's disease of bone	0.000199	0.000742	CcSEcCtD
Imatinib—Pain—Zoledronate—Paget's disease of bone	0.000199	0.000742	CcSEcCtD
Imatinib—Nausea—Alendronate—Paget's disease of bone	0.000198	0.00074	CcSEcCtD
Imatinib—Hypersensitivity—Risedronate—Paget's disease of bone	0.000197	0.000736	CcSEcCtD
Imatinib—Asthenia—Risedronate—Paget's disease of bone	0.000192	0.000717	CcSEcCtD
Imatinib—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000191	0.000715	CcSEcCtD
Imatinib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00019	0.00071	CcSEcCtD
Imatinib—Pruritus—Risedronate—Paget's disease of bone	0.000189	0.000707	CcSEcCtD
Imatinib—CA3—Metabolism—NUP205—Paget's disease of bone	0.000189	0.0046	CbGpPWpGaD
Imatinib—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000187	0.0007	CcSEcCtD
Imatinib—Urticaria—Zoledronate—Paget's disease of bone	0.000185	0.00069	CcSEcCtD
Imatinib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000184	0.000686	CcSEcCtD
Imatinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000184	0.000686	CcSEcCtD
Imatinib—Diarrhoea—Risedronate—Paget's disease of bone	0.000183	0.000684	CcSEcCtD
Imatinib—Asthenia—Pamidronate—Paget's disease of bone	0.000183	0.000682	CcSEcCtD
Imatinib—Pruritus—Pamidronate—Paget's disease of bone	0.00018	0.000672	CcSEcCtD
Imatinib—Dizziness—Risedronate—Paget's disease of bone	0.000177	0.000661	CcSEcCtD
Imatinib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000174	0.00065	CcSEcCtD
Imatinib—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000171	0.000639	CcSEcCtD
Imatinib—Vomiting—Risedronate—Paget's disease of bone	0.00017	0.000636	CcSEcCtD
Imatinib—Rash—Risedronate—Paget's disease of bone	0.000169	0.00063	CcSEcCtD
Imatinib—Dermatitis—Risedronate—Paget's disease of bone	0.000169	0.00063	CcSEcCtD
Imatinib—Dizziness—Pamidronate—Paget's disease of bone	0.000168	0.000628	CcSEcCtD
Imatinib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.000168	0.00409	CbGpPWpGaD
Imatinib—Headache—Risedronate—Paget's disease of bone	0.000168	0.000626	CcSEcCtD
Imatinib—Asthenia—Zoledronate—Paget's disease of bone	0.000167	0.000623	CcSEcCtD
Imatinib—Pruritus—Zoledronate—Paget's disease of bone	0.000164	0.000614	CcSEcCtD
Imatinib—Vomiting—Pamidronate—Paget's disease of bone	0.000162	0.000604	CcSEcCtD
Imatinib—CA3—Metabolism—INPP5D—Paget's disease of bone	0.000161	0.00392	CbGpPWpGaD
Imatinib—Rash—Pamidronate—Paget's disease of bone	0.00016	0.000599	CcSEcCtD
Imatinib—Dermatitis—Pamidronate—Paget's disease of bone	0.00016	0.000599	CcSEcCtD
Imatinib—Headache—Pamidronate—Paget's disease of bone	0.000159	0.000595	CcSEcCtD
Imatinib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000159	0.000594	CcSEcCtD
Imatinib—Nausea—Risedronate—Paget's disease of bone	0.000159	0.000594	CcSEcCtD
Imatinib—Dizziness—Zoledronate—Paget's disease of bone	0.000154	0.000574	CcSEcCtD
Imatinib—Nausea—Pamidronate—Paget's disease of bone	0.000151	0.000564	CcSEcCtD
Imatinib—KIT—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00015	0.00365	CbGpPWpGaD
Imatinib—Vomiting—Zoledronate—Paget's disease of bone	0.000148	0.000552	CcSEcCtD
Imatinib—Rash—Zoledronate—Paget's disease of bone	0.000147	0.000547	CcSEcCtD
Imatinib—Dermatitis—Zoledronate—Paget's disease of bone	0.000146	0.000547	CcSEcCtD
Imatinib—Headache—Zoledronate—Paget's disease of bone	0.000146	0.000544	CcSEcCtD
Imatinib—PDGFRA—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000142	0.00345	CbGpPWpGaD
Imatinib—SLC22A2—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000139	0.00338	CbGpPWpGaD
Imatinib—Nausea—Zoledronate—Paget's disease of bone	0.000138	0.000516	CcSEcCtD
Imatinib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000137	0.00332	CbGpPWpGaD
Imatinib—SLC22A1—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.00013	0.00315	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000128	0.00311	CbGpPWpGaD
Imatinib—CA14—Metabolism—NUP205—Paget's disease of bone	0.000122	0.00296	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000121	0.00294	CbGpPWpGaD
Imatinib—CA6—Metabolism—NUP205—Paget's disease of bone	0.000119	0.00289	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000117	0.00283	CbGpPWpGaD
Imatinib—CA7—Metabolism—NUP205—Paget's disease of bone	0.000111	0.00269	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000104	0.00254	CbGpPWpGaD
Imatinib—CA14—Metabolism—INPP5D—Paget's disease of bone	0.000104	0.00253	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000103	0.0025	CbGpPWpGaD
Imatinib—CA12—Metabolism—NUP205—Paget's disease of bone	0.000103	0.0025	CbGpPWpGaD
Imatinib—CA6—Metabolism—INPP5D—Paget's disease of bone	0.000101	0.00246	CbGpPWpGaD
Imatinib—CA7—Metabolism—INPP5D—Paget's disease of bone	9.45e-05	0.0023	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—INPP5D—Paget's disease of bone	9.17e-05	0.00223	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	8.81e-05	0.00214	CbGpPWpGaD
Imatinib—CA12—Metabolism—INPP5D—Paget's disease of bone	8.75e-05	0.00213	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—INPP5D—Paget's disease of bone	8.68e-05	0.00211	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	8.67e-05	0.00211	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	8.59e-05	0.00209	CbGpPWpGaD
Imatinib—KIT—Disease—VCP—Paget's disease of bone	7.88e-05	0.00192	CbGpPWpGaD
Imatinib—CA2—Metabolism—NUP205—Paget's disease of bone	7.85e-05	0.00191	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—INPP5D—Paget's disease of bone	7.82e-05	0.0019	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—VCP—Paget's disease of bone	7.53e-05	0.00183	CbGpPWpGaD
Imatinib—CA1—Metabolism—NUP205—Paget's disease of bone	7.52e-05	0.00183	CbGpPWpGaD
Imatinib—PDGFRA—Disease—VCP—Paget's disease of bone	7.46e-05	0.00181	CbGpPWpGaD
Imatinib—LCK—Hemostasis—INPP5D—Paget's disease of bone	7.26e-05	0.00176	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	7.14e-05	0.00174	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	7.06e-05	0.00172	CbGpPWpGaD
Imatinib—PDGFRB—Disease—VCP—Paget's disease of bone	6.72e-05	0.00163	CbGpPWpGaD
Imatinib—CA2—Metabolism—INPP5D—Paget's disease of bone	6.69e-05	0.00163	CbGpPWpGaD
Imatinib—CA9—Metabolism—NUP205—Paget's disease of bone	6.61e-05	0.00161	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	6.58e-05	0.0016	CbGpPWpGaD
Imatinib—KIT—Immune System—NUP205—Paget's disease of bone	6.52e-05	0.00159	CbGpPWpGaD
Imatinib—CA1—Metabolism—INPP5D—Paget's disease of bone	6.42e-05	0.00156	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	6.27e-05	0.00153	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NUP205—Paget's disease of bone	6.17e-05	0.0015	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	6.15e-05	0.0015	CbGpPWpGaD
Imatinib—KIT—Disease—NUP205—Paget's disease of bone	6.02e-05	0.00146	CbGpPWpGaD
Imatinib—KIT—Immune System—PML—Paget's disease of bone	5.76e-05	0.0014	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NUP205—Paget's disease of bone	5.7e-05	0.00139	CbGpPWpGaD
Imatinib—CA9—Metabolism—INPP5D—Paget's disease of bone	5.64e-05	0.00137	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NUP205—Paget's disease of bone	5.56e-05	0.00135	CbGpPWpGaD
Imatinib—KIT—Immune System—INPP5D—Paget's disease of bone	5.56e-05	0.00135	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VCP—Paget's disease of bone	5.52e-05	0.00134	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—PML—Paget's disease of bone	5.46e-05	0.00133	CbGpPWpGaD
Imatinib—ABL1—Immune System—NUP205—Paget's disease of bone	5.42e-05	0.00132	CbGpPWpGaD
Imatinib—LCK—Disease—VCP—Paget's disease of bone	5.39e-05	0.00131	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—INPP5D—Paget's disease of bone	5.26e-05	0.00128	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VCP—Paget's disease of bone	5.22e-05	0.00127	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NUP205—Paget's disease of bone	5.13e-05	0.00125	CbGpPWpGaD
Imatinib—KIT—Immune System—SQSTM1—Paget's disease of bone	4.98e-05	0.00121	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—PML—Paget's disease of bone	4.92e-05	0.0012	CbGpPWpGaD
Imatinib—ABL1—Immune System—PML—Paget's disease of bone	4.79e-05	0.00116	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—INPP5D—Paget's disease of bone	4.74e-05	0.00115	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—SQSTM1—Paget's disease of bone	4.72e-05	0.00115	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VCP—Paget's disease of bone	4.7e-05	0.00114	CbGpPWpGaD
Imatinib—ABL1—Immune System—INPP5D—Paget's disease of bone	4.62e-05	0.00112	CbGpPWpGaD
Imatinib—KIT—Disease—CALCA—Paget's disease of bone	4.47e-05	0.00109	CbGpPWpGaD
Imatinib—LCK—Immune System—NUP205—Paget's disease of bone	4.46e-05	0.00109	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	4.4e-05	0.00107	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—SQSTM1—Paget's disease of bone	4.4e-05	0.00107	CbGpPWpGaD
Imatinib—ALB—Hemostasis—INPP5D—Paget's disease of bone	4.34e-05	0.00106	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CALCA—Paget's disease of bone	4.27e-05	0.00104	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—SQSTM1—Paget's disease of bone	4.25e-05	0.00103	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CALCA—Paget's disease of bone	4.23e-05	0.00103	CbGpPWpGaD
Imatinib—ABL1—Immune System—SQSTM1—Paget's disease of bone	4.14e-05	0.00101	CbGpPWpGaD
Imatinib—LCK—Disease—NUP205—Paget's disease of bone	4.12e-05	0.001	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.95e-05	0.000961	CbGpPWpGaD
Imatinib—LCK—Immune System—PML—Paget's disease of bone	3.94e-05	0.000959	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	3.86e-05	0.000938	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CALCA—Paget's disease of bone	3.81e-05	0.000927	CbGpPWpGaD
Imatinib—LCK—Immune System—INPP5D—Paget's disease of bone	3.81e-05	0.000925	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VCP—Paget's disease of bone	3.78e-05	0.000918	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.55e-05	0.000862	CbGpPWpGaD
Imatinib—LCK—Immune System—SQSTM1—Paget's disease of bone	3.41e-05	0.00083	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NUP205—Paget's disease of bone	3.34e-05	0.000813	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NUP205—Paget's disease of bone	3.31e-05	0.000806	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NUP205—Paget's disease of bone	3.31e-05	0.000805	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.23e-05	0.000786	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—SQSTM1—Paget's disease of bone	3.22e-05	0.000784	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NUP205—Paget's disease of bone	3.21e-05	0.000781	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CALCA—Paget's disease of bone	3.13e-05	0.000761	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NUP205—Paget's disease of bone	3.08e-05	0.00075	CbGpPWpGaD
Imatinib—LCK—Disease—CALCA—Paget's disease of bone	3.06e-05	0.000744	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—SQSTM1—Paget's disease of bone	3.05e-05	0.000742	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CALCA—Paget's disease of bone	2.96e-05	0.00072	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—INPP5D—Paget's disease of bone	2.85e-05	0.000693	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—INPP5D—Paget's disease of bone	2.83e-05	0.000687	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—INPP5D—Paget's disease of bone	2.82e-05	0.000686	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	2.76e-05	0.000672	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—SQSTM1—Paget's disease of bone	2.75e-05	0.000668	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—INPP5D—Paget's disease of bone	2.74e-05	0.000666	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CALCA—Paget's disease of bone	2.67e-05	0.000649	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—INPP5D—Paget's disease of bone	2.63e-05	0.000639	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NUP205—Paget's disease of bone	2.4e-05	0.000582	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	2.21e-05	0.000536	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	2.14e-05	0.000521	CbGpPWpGaD
Imatinib—ALB—Metabolism—NUP205—Paget's disease of bone	2.06e-05	0.000502	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—INPP5D—Paget's disease of bone	2.04e-05	0.000497	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NUP205—Paget's disease of bone	1.85e-05	0.00045	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NUP205—Paget's disease of bone	1.81e-05	0.00044	CbGpPWpGaD
Imatinib—ALB—Metabolism—INPP5D—Paget's disease of bone	1.76e-05	0.000428	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NUP205—Paget's disease of bone	1.7e-05	0.000414	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NUP205—Paget's disease of bone	1.69e-05	0.000411	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—INPP5D—Paget's disease of bone	1.58e-05	0.000384	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	1.54e-05	0.000375	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	1.45e-05	0.000353	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NUP205—Paget's disease of bone	1.44e-05	0.000351	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	1.44e-05	0.00035	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	1.23e-05	0.000299	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	1.11e-05	0.000271	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	9.5e-06	0.000231	CbGpPWpGaD
